Intercept Pharmaceuticals | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amarin USD 106.73M 15.54M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Arrowhead Research USD 2.36M 135K 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Biogen USD 2B 127.7M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
PTC Therapeutics USD 210.5M 51.94M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Intercept Pharmaceuticals Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.